The device "Lock Sheath" used in cardiac catheterization examinations announced in early July that it would stop supplying it in Taiwan, which may prolong the operation time of patients. (Taiwan’s “China Times” file photo) China Economic Times quoted Taiwan’s “China Times” on Sep

The "lock sheath" device used for cardiac catheterization examinations announced in early July that it would stop supplying it in Taiwan, which may prolong the operation time of patients. (Taiwan’s “China Times” file photo)

China Economic Times quoted Taiwan’s “China Times” on September 20 as reporting that a commonly used instrument for cardiac catheterization examinations, the “locksheath”, has caused overseas manufacturers to suffer losses. 7 At the beginning of the month, it announced that it would abandon the Taiwan market. KMT public opinion representative Li Yanxiu said bluntly that when Taiwan was seriously short of medicines in February last year, the health and welfare departments of the Taiwan authorities proposed countermeasures to solve the problem. However, after one and a half years, the so-called comprehensive review is still an endless meeting and discussion. If it is just a mouthful of hope for community Times are tough, how many pharmaceutical companies can continue to grit their teeth and hold on? Some Taiwanese netizens questioned that Taiwan’s medical care has been messed up. Doesn’t Qingniao (a supporter of the Democratic Progressive Party) have no elders? He said directly, "It's okay to blame Lan Bai", "It's okay to import snack bars through project projects", and "Father and mother are not as good as party relatives".

Shi Banyu, a well-known voice actor on the island, was reported to have passed away due to myocardial infarction, and issues related to cardiac catheterization have once again attracted attention. Taiwan's "ettoday News Cloud" reported that Li Yanxiu said that discussions such as "low health insurance benefits" and "medical equipment withdrawing from the Taiwan market due to insufficient costs" have been on the news recently, but this time the equipment used for cardiac catheterization examinations that has attracted much attention is "lockable" "Sheath" is actually just the tip of the iceberg of Taiwan's health insurance problem.

Li Yanxiu pointed out that when the search keyword "drugs withdraw from Taiwan" is used, what comes into view is the media report last month that the blood pressure drug "Aprenovir" and the antidepressant drug "Prozac" will be withdrawn in November. In the Taiwan market, the Taiwan Pharmacists Association also analyzed that a total of 13 original drugs have withdrawn from the Taiwan market in the past 10 years. Unfortunately, the Taiwan authorities’ Food and Drug Administration always uses “there are many alternative drugs” as excuses. There seems to be an excuse. The system is seriously ill. They can turn a blind eye and pass on the communication costs and adaptation costs of dressing changes to the medical community and the public.

"Every lack of medicine means that people are urgently waiting for treatment and that people's health is threatened by diseases!" Li Yanxiu emphasized that in the past year, medicines for lowering cholesterol, diabetes, cataracts, antivomiting and coughing, as well as surgery and kidney dialysis Physiological saline solution, there are reports of drug shortages one after another. The reason may be raw material supply problems or original factory supply policies. However, leaving aside these individual drug supply problems, fundamentally speaking, it is insufficient health insurance resources, excessive exploitation of health insurance benefits, and drug shortages. When the factory was overwhelmed, they naturally left in droves.

Li Yanxiu questioned that when Taiwan's drug shortage was serious in February last year, although Taiwan's health and welfare department proposed a number of countermeasures to solve the drug shortage problem, including a "comprehensive review of the national health insurance drug price policy", after one and a half years, the so-called comprehensive review is still There are endless meetings and discussions, and only the sound of the stairs cannot keep the medicines that are crucial to the health and safety of the people. Not only that, during the negotiations on the total amount of national health insurance in the past two years, the National Health Insurance Administration did not see a sufficient budget to comprehensively review the drug payment standards. If they just expressed hope for the community's hard times, how many pharmaceutical companies can continue to grit their teeth?

Some netizens wrote bluntly: I am curious, Taiwan’s medical treatment is so messed up, from skin medicine to depression medicine and now cardiac catheterization has been withdrawn, a blue bird or a black bear is so happy? Are there no elders in the family? Discrediting the fact that imported medical materials are similar to those produced in Taiwan, can this really be considered a problem? Can you really say this to the elders in your family when they need it?

villagers said: "If something goes wrong, just blame Blue and White for blocking it." "When necessary, buy it at a high price, saying that demand is greater than supply; then Blue and White says it is too expensive and needs detailed information, and Green will say that Blue and White is blocking life-saving money." "The blue bird will be recommended to Lan Bai" "If you really need it, just find a snack bar project to buy, the DPP's saucy operations in the past few years" "My experience is that when there is nothing in health insurance, you should call it, but it turns out you really need to use it. Sometimes I think it’s better to pay for it at my own expense.” “It’s better to just import the project. Isn’t it like this in the past few years?” “Father and mother are not as good as party members.”[Source: China Jingwei Network]